Search research articles
Contact Us
Filters
Showing results (681-690 of 730) with videos related to
Page
of 73
Sort By:
Journal of the National Cancer Institute
|
November 21, 2017
MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization
Christopher J Walker, Craig M Rush, Paola Dama, et al.
Obesity (Silver Spring, Md.)
|
November 4, 2024
Changes in anthropometry, adiposity, and inflammation in Black and White women engaged in intentional weight loss
Ashley S Felix, Jennifer A Sinnott, Bette J Caan, et al.
Gynecologic Oncology
|
May 27, 2026
Beyond extrapolation: Immunotherapy outcomes in recurrent vulvovaginal carcinoma
Cassidy S Abdeen, Reed M O'Connor, Julia Chalif, et al.
The Journal of Infectious Diseases
|
August 10, 2006
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068
Jeffrey M Jacobson, R Pat Bucy, John Spritzler, et al.
The Lancet. HIV
|
October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial
Robert Gross, Lu Zheng, Alberto La Rosa, et al.
Gynecologic Oncology
|
December 7, 2002
Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy
Jeanne M Schilder, Amy M Thompson, Paul D DePriest, et al.
Gynecologic Oncology
|
July 16, 2017
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival
Casey M Cosgrove, David E Cohn, Heather Hampel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2016
A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)
P H Thaker, R Salani, W E Brady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer
Alexi A Wright, Angel Cronin, Dana E Milne, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 28, 2020
Prevalence of hepatitis B virus infection in pregnant women with and without HIV in Jos, Nigeria
Francis A Magaji, Mark O Okolo, Esther S Yiltok, et al.
Page
of 73
Search research articles
Search
Showing results (681-690 of 730) with videos related to
Sort By:
Page
of 73
Journal of the National Cancer Institute
|
November 21, 2017
MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization
Christopher J Walker, Craig M Rush, Paola Dama, et al.
Obesity (Silver Spring, Md.)
|
November 4, 2024
Changes in anthropometry, adiposity, and inflammation in Black and White women engaged in intentional weight loss
Ashley S Felix, Jennifer A Sinnott, Bette J Caan, et al.
Gynecologic Oncology
|
May 27, 2026
Beyond extrapolation: Immunotherapy outcomes in recurrent vulvovaginal carcinoma
Cassidy S Abdeen, Reed M O'Connor, Julia Chalif, et al.
The Journal of Infectious Diseases
|
August 10, 2006
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068
Jeffrey M Jacobson, R Pat Bucy, John Spritzler, et al.
The Lancet. HIV
|
October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial
Robert Gross, Lu Zheng, Alberto La Rosa, et al.
Gynecologic Oncology
|
December 7, 2002
Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy
Jeanne M Schilder, Amy M Thompson, Paul D DePriest, et al.
Gynecologic Oncology
|
July 16, 2017
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival
Casey M Cosgrove, David E Cohn, Heather Hampel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2016
A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)
P H Thaker, R Salani, W E Brady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer
Alexi A Wright, Angel Cronin, Dana E Milne, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 28, 2020
Prevalence of hepatitis B virus infection in pregnant women with and without HIV in Jos, Nigeria
Francis A Magaji, Mark O Okolo, Esther S Yiltok, et al.
Page
of 73